Citigroup
AMED

Citigroup’s Amedisys AMED Stock Holding History

Citigroup’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-189,966
Closed -$18.7M – 6068
2025
Q2 		$18.7M Buy
189,966
+11,512
+6% +$1.09M 0.01% 1004
2025
Q1 		$16.5M Sell
178,454
-16,490
-8% -$1.52M 0.01% 1064
2024
Q4 		$17.7M Buy
194,944
+2,176
+1% +$200K 0.01% 1035
2024
Q3 		$18.6M Buy
192,768
+12,911
+7% +$1.26M 0.01% 978
2024
Q2 		$16.5M Sell
179,857
-8,270
-4% -$767K 0.01% 976
2024
Q1 		$17.3M Sell
188,127
-3,029
-2% -$284K 0.01% 953
2023
Q4 		$18.2M Buy
191,156
+10,053
+6% +$939K 0.01% 897
2023
Q3 		$16.9M Buy
181,103
+1,326
+0.7% +$123K 0.01% 859
2023
Q2 		$16.4M Buy
179,777
+168,205
+1,454% +$13.8M 0.01% 917
2023
Q1 		$851K Buy
11,572
+1,250
+12% +$108K ﹤0.01% 2678
2022
Q4 		$862K Sell
10,322
-5,573
-35% -$502K ﹤0.01% 2754
2022
Q3 		$1.54M Buy
15,895
+4,983
+46% +$594K ﹤0.01% 2355
2022
Q2 		$1.15M Sell
10,912
-2,356
-18% -$301K ﹤0.01% 2544
2022
Q1 		$2.29M Buy
13,268
+803
+6% +$120K ﹤0.01% 2263
2021
Q4 		$2.02M Sell
12,465
-8,768
-41% -$1.41M ﹤0.01% 2615
2021
Q3 		$3.17M Sell
21,233
-16,848
-44% -$3.5M ﹤0.01% 2143
2021
Q2 		$9.33M Sell
38,081
-36,034
-49% -$9.45M 0.01% 1472
2021
Q1 		$19.6M Buy
74,115
+22,137
+43% +$6.24M 0.01% 967
2020
Q4 		$15.2M Buy
51,978
+21,421
+70% +$5.49M 0.01% 1229
2020
Q3 		$7.22M Sell
30,557
-57,773
-65% -$13.1M ﹤0.01% 1636
2020
Q2 		$17.5M Buy
88,330
+60,806
+221% +$11.3M 0.01% 905
2020
Q1 		$5.05M Buy
27,524
+826
+3% +$147K ﹤0.01% 1670
2019
Q4 		$4.46M Buy
26,698
+19,751
+284% +$2.94M ﹤0.01% 2124
2019
Q3 		$910K Sell
6,947
-19,440
-74% -$2.53M ﹤0.01% 3737
2019
Q2 		$3.2M Sell
26,387
-2,140
-8% -$254K ﹤0.01% 2344
2019
Q1 		$3.52M Buy
28,527
+15,890
+126% +$1.99M ﹤0.01% 2096
2018
Q4 		$1.48M Sell
12,637
-9,127
-42% -$1.08M ﹤0.01% 2975
2018
Q3 		$2.72M Buy
21,764
+14,299
+192% +$1.58M ﹤0.01% 2443
2018
Q2 		$639K Sell
7,465
-5,567
-43% -$409K ﹤0.01% 3830
2018
Q1 		$786K Buy
13,032
+1,797
+16% +$102K ﹤0.01% 3492
2017
Q4 		$592K Sell
11,235
-8,917
-44% -$470K ﹤0.01% 3932
2017
Q3 		$1.13M Sell
20,152
-3,753
-16% -$198K ﹤0.01% 3242
2017
Q2 		$1.5M Sell
23,905
-569
-2% -$33.1K ﹤0.01% 2889
2017
Q1 		$1.25M Sell
24,474
-27,454
-53% -$1.31M ﹤0.01% 2981
2016
Q4 		$2.21M Buy
51,928
+32,722
+170% +$1.39M ﹤0.01% 2816
2016
Q3 		$911K Buy
19,206
+7,097
+59% +$354K ﹤0.01% 3313
2016
Q2 		$611K Sell
12,109
-7,939
-40% -$401K ﹤0.01% 3438
2016
Q1 		$969K Buy
20,048
+19,867
+10,976% +$767K ﹤0.01% 3381
2015
Q4 		$7K Sell
181
-3
-2% -$120 ﹤0.01% 6919
2015
Q3 		$7K Sell
184
-462
-72% -$19.5K ﹤0.01% 6586
2015
Q2 		$26K Sell
646
-305
-32% -$9.5K ﹤0.01% 5949
2015
Q1 		$26K Sell
951
-31,221
-97% -$881K ﹤0.01% 5931
2014
Q4 		$944K Buy
32,172
+8,014
+33% +$198K ﹤0.01% 3198
2014
Q3 		$488K Buy
24,158
+672
+3% +$13K ﹤0.01% 3552
2014
Q2 		$393K Sell
23,486
-24,986
-52% -$354K ﹤0.01% 3622
2014
Q1 		$721K Sell
48,472
-13,329
-22% -$205K ﹤0.01% 3149
2013
Q4 		$904K Buy
61,801
+44,147
+250% +$711K ﹤0.01% 3272
2013
Q3 		$303K Sell
17,654
-11,017
-38% -$163K ﹤0.01% 3823
2013
Q2 		$334K Buy
+28,671
New +$328K ﹤0.01% 3825

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Citigroup's AMED Position: Q3 2025 in Review

Citigroup sold out of Amedisys (AMED) in Q3 2025, closing a stake of 189,966 shares — an estimated $18.7M sold.

Citigroup first reported a position in AMED in Q2 2013 and held it in 49 quarters. The position peaked at $19.6M in Q1 2021. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Citigroup reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Citigroup sold 189,966 Amedisys shares in Q3 2025, an estimated $18.7M.
  • Citigroup first reported a position in Amedisys in Q2 2013 and held it in 49 quarters.
  • Citigroup's Amedisys position peaked at $19.6M in Q1 2021.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Citigroup's 13F filing for Q3 2025, filed 10 Nov 2025.